89bio (ETNB) News Today $9.16 -0.33 (-3.48%) Closing price 05/27/2025 04:00 PM EasternExtended Trading$9.15 -0.01 (-0.11%) As of 05/27/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETNB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Woodline Partners LP Grows Stake in 89bio, Inc. (NASDAQ:ETNB)Woodline Partners LP grew its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 640.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 394,826 shares of the company's stock after acquiring an additional 341,479 shares during the quarteMay 27 at 4:37 AM | marketbeat.com89bio (NASDAQ:ETNB) Earns "Sell (D-)" Rating from Weiss RatingsMay 27 at 3:53 AM | americanbankingnews.com89bio (NASDAQ:ETNB) Receives "Sell (D-)" Rating from Weiss RatingsMay 27 at 3:15 AM | americanbankingnews.comRafferty Asset Management LLC Has $694,000 Stake in 89bio, Inc. (NASDAQ:ETNB)Rafferty Asset Management LLC lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 30.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 88,745 shares of the company's stock after selling 38,636 shares during the period. Rafferty Asset ManagMay 25 at 4:04 AM | marketbeat.comNorthern Trust Corp Increases Stake in 89bio, Inc. (NASDAQ:ETNB)Northern Trust Corp lifted its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 7.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 854,787 shares of the company's stock after acquiring an additional 60,075 shares during the period.May 22, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) is Suvretta Capital Management LLC's 8th Largest PositionSuvretta Capital Management LLC lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 27.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,202,696 shares of the company's stock after purchasingMay 19, 2025 | marketbeat.comRTW Investments LP Increases Stake in 89bio, Inc. (NASDAQ:ETNB)RTW Investments LP boosted its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 1.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 7,478,061 shares of the company's stock after purchasing an additional 99,513 shares during the quarter.May 18, 2025 | marketbeat.comBNP Paribas Financial Markets Takes Position in 89bio, Inc. (NASDAQ:ETNB)BNP Paribas Financial Markets purchased a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 351,331 shares of the company's stock, valued at approximately $2,747,000. BNP ParMay 18, 2025 | marketbeat.comDimensional Fund Advisors LP Buys New Stake in 89bio, Inc. (NASDAQ:ETNB)Dimensional Fund Advisors LP purchased a new stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 342,229 shares of the company's stock, valued at approximately $2,67May 17, 2025 | marketbeat.comJanus Henderson Group PLC Boosts Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)Janus Henderson Group PLC grew its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 8.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,514,056 shares of the company's stock after purchasing aMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Has $7.82 Million Holdings in 89bio, Inc. (NASDAQ:ETNB)Integral Health Asset Management LLC increased its position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 100.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,000,000 shares of the company's stock after buyinMay 14, 2025 | marketbeat.comIs Now the Time to Buy Biotech Stocks?May 13, 2025 | finance.yahoo.comBalyasny Asset Management L.P. Purchases Shares of 1,019,449 89bio, Inc. (NASDAQ:ETNB)Balyasny Asset Management L.P. acquired a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 1,019,449 shares of the company's stock, valued at approximately $7,97May 12, 2025 | marketbeat.comAlgert Global LLC Boosts Stock Position in 89bio, Inc. (NASDAQ:ETNB)Algert Global LLC lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 198.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 185,407 shares of the company's stock after purchasing an additional 123,190 shares duringMay 12, 2025 | marketbeat.comWeiss Ratings Reaffirms "Sell (D-)" Rating for 89bio (NASDAQ:ETNB)Weiss Ratings restated a "sell (d-)" rating on shares of 89bio in a research note on Saturday.May 12, 2025 | marketbeat.com89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 9, 2025 | globenewswire.comDeep Track Capital LP Buys 3,711,737 Shares of 89bio, Inc. (NASDAQ:ETNB)Deep Track Capital LP increased its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 134.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,478,249 shares of the company's stock after purchasing an additional 3,711,737 shMay 9, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Alyeska Investment Group L.P.Alyeska Investment Group L.P. increased its holdings in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 14.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 925,397 shares of the company's stock after buying an aMay 8, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of "Buy" by Brokerages89bio, Inc. (NASDAQ:ETNB - Get Free Report) has been assigned a consensus rating of "Buy" from the nine research firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendationMay 8, 2025 | marketbeat.com89bio to Participate in Upcoming Investor ConferencesMay 6, 2025 | globenewswire.com89bio, Inc. (NASDAQ:ETNB) Shares Sold by BVF Inc. ILBVF Inc. IL trimmed its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 36.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,333,885 shares of the company's stock after selling 2,477,746 shares during the quMay 6, 2025 | marketbeat.com60,992 Shares in 89bio, Inc. (NASDAQ:ETNB) Purchased by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC acquired a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 60,992 shares of the company's stocMay 6, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS89bio (NASDAQ:ETNB - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.50) by $0.01. During the same period in the prior year, the firm posted ($0.54) earnings per share.May 5, 2025 | marketbeat.comEquities Analysts Issue Forecasts for 89bio FY2025 Earnings89bio, Inc. (NASDAQ:ETNB - Free Report) - Cantor Fitzgerald issued their FY2025 earnings per share estimates for 89bio in a research note issued on Wednesday, April 30th. Cantor Fitzgerald analyst S. Seedhouse expects that the company will earn ($3.35) per share for the year. Cantor Fitzgerald hMay 4, 2025 | marketbeat.comAlly Bridge Group NY LLC Takes Position in 89bio, Inc. (NASDAQ:ETNB)Ally Bridge Group NY LLC purchased a new position in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 317,833 shares of the company's stock, valued aMay 4, 2025 | marketbeat.comPDT Partners LLC Cuts Stake in 89bio, Inc. (NASDAQ:ETNB)PDT Partners LLC reduced its holdings in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 52.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,918 shares of the company's stock after selling 88,327 shares dMay 4, 2025 | marketbeat.comCantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to "Strong-Buy"Cantor Fitzgerald raised shares of 89bio to a "strong-buy" rating in a research note on Wednesday.May 3, 2025 | marketbeat.com89bio (ETNB) Projected to Post Quarterly Earnings on Thursday89bio (NASDAQ:ETNB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-89bio-inc-stock/)May 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 525,000 Shares of 89bio, Inc. (NASDAQ:ETNB)Adage Capital Partners GP L.L.C. lowered its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 60.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 350,000 shares of the company's stock after selling 525,000 sMay 2, 2025 | marketbeat.com89bio Reports First Quarter 2025 Financial Results and Corporate UpdatesMay 1, 2025 | globenewswire.com89bio (NASDAQ:ETNB) Stock Price Up 4.5% - Time to Buy?89bio (NASDAQ:ETNB) Stock Price Up 4.5% - Time to Buy?April 30, 2025 | marketbeat.comRaymond James Financial Inc. Acquires Shares of 377,370 89bio, Inc. (NASDAQ:ETNB)Raymond James Financial Inc. bought a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 377,370 shares of the company's stock, valued at approximatelyApril 30, 2025 | marketbeat.comBarclays PLC Buys 425,206 Shares of 89bio, Inc. (NASDAQ:ETNB)Barclays PLC lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 198.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 639,974 shares of the company's stock after purApril 29, 2025 | marketbeat.com89bio's (ETNB) "Sell (D-)" Rating Reiterated at Weiss RatingsWeiss Ratings reissued a "sell (d-)" rating on shares of 89bio in a research report on Thursday.April 27, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Purchased by JPMorgan Chase & Co.JPMorgan Chase & Co. lifted its stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) by 210.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 308,459 shares of the company's stock after acquiringApril 26, 2025 | marketbeat.comInvestors Buy Large Volume of 89bio Put Options (NASDAQ:ETNB)89bio, Inc. (NASDAQ:ETNB - Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors purchased 12,935 put options on the stock. This is an increase of 1,544% compared to the average daily volume of 787 put options.April 24, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Trading Up 6.1% - Time to Buy?89bio (NASDAQ:ETNB) Stock Price Up 6.1% - Time to Buy?April 23, 2025 | marketbeat.comAvoro Capital Advisors LLC Makes New Investment in 89bio, Inc. (NASDAQ:ETNB)Avoro Capital Advisors LLC purchased a new stake in shares of 89bio, Inc. (NASDAQ:ETNB - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,100,000 shares of the company's stock, valued at approximately $32,April 23, 2025 | marketbeat.comRock Springs Capital Management LP Makes New Investment in 89bio, Inc. (NASDAQ:ETNB)Rock Springs Capital Management LP purchased a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 552,741 shares of the company's stock, valued at appApril 23, 2025 | marketbeat.comGeode Capital Management LLC Grows Position in 89bio, Inc. (NASDAQ:ETNB)Geode Capital Management LLC raised its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 6.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,207,608 shares of the company's stock after acquiring an additionalApril 21, 2025 | marketbeat.comShort Interest in 89bio, Inc. (NASDAQ:ETNB) Grows By 38.3%89bio, Inc. (NASDAQ:ETNB - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 15,230,000 shares, an increase of 38.3% from the March 15th total of 11,010,000 shares. Based on an average daily trading volume, of 2,540,000 shares, the short-interest ratio is currently 6.0 days. Currently, 14.8% of the shares of the company are sold short.April 20, 2025 | marketbeat.comQuoc Le-Nguyen Sells 15,329 Shares of 89bio, Inc. (NASDAQ:ETNB) StockApril 18, 2025 | insidertrades.com89bio: A Buy With Strong Market Opportunity In MASH And SHTGApril 18, 2025 | seekingalpha.com89bio: Primary Asset Targeting 2 Potential Indications And Is In Late-Stage DevelopmentApril 17, 2025 | seekingalpha.comUniversity of Wisconsin Foundation Purchases 193,225 Shares of 89bio, Inc. (NASDAQ:ETNB)University of Wisconsin Foundation raised its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 26.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 917,357 shares of the company's stock after acquiring an additional 193,225 shares dApril 15, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Alliancebernstein L.P.Alliancebernstein L.P. boosted its stake in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 77.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,042,136 shares of the company's stock after purchasing an additional 455,074 shares during the period. AlliancebernsteiApril 14, 2025 | marketbeat.comVanguard Group Inc. Grows Stock Holdings in 89bio, Inc. (NASDAQ:ETNB)Vanguard Group Inc. grew its position in 89bio, Inc. (NASDAQ:ETNB - Free Report) by 13.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,692,331 shares of the company's stock after buying an additional 686,054 shares during the pApril 14, 2025 | marketbeat.com89bio, Inc. (NASDAQ:ETNB) Given Average Recommendation of "Moderate Buy" by Analysts89bio, Inc. (NASDAQ:ETNB - Get Free Report) has received an average rating of "Moderate Buy" from the ten analysts that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommenApril 13, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Sets New 1-Year Low - Time to Sell?89bio (NASDAQ:ETNB) Sets New 12-Month Low - What's Next?April 12, 2025 | marketbeat.com89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss RatingsWeiss Ratings reaffirmed a "sell (d-)" rating on shares of 89bio in a research note on Tuesday.April 10, 2025 | marketbeat.com Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.931.03▲Average Medical News Sentiment ETNB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼75▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Legend Biotech News Nuvalent News Axsome Therapeutics News Lantheus News ADMA Biologics News Vaxcyte News Rhythm Pharmaceuticals News Merus News Sarepta Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETNB) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 89bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ETNB Stock Free ETNB Stock Alerts